TLRY Tilray Brands Inc
TLRY Cannabis Stock CRON Trades Near 52-Week High: How to Play
Cronos trades near its 52-week high as international growth boosts sales, but losses and stiff competition weigh on its outlook.
Zacks·5h ago
Tilray Brands, Inc. (TLRY) Dips More Than Broader Market: What You Should Know
In the latest trading session, Tilray Brands, Inc. (TLRY) closed at $1.25, marking a -9.42% move from the previous day.
Zacks·3d ago
Tilray Brands, Inc. (TLRY) Stock Falls Amid Market Uptick: What Investors Need to Know
The latest trading day saw Tilray Brands, Inc. (TLRY) settling at $1.37, representing a -5.52% change from its previous close.
Zacks·9d ago
Opendoor, Aehr, Intel, Tilray, Keurig: Stocks Making The Biggest Moves Today
Opendoor shares soared over 13% on Monday and emerged as the top trending ticker on the Stocktwits platform, with investors sounding optimistic following Federal Reserve Chair Jerome Powell’s Jackson Hole speech.
Why Did Tilray Stock Shoot Up 20% Today? Jefferies Price Target Boost, Trump’s Cannabis Reclassification In Focus
Jefferies raised its price target to $2 from $1.50 and noted that U.S. President Donald Trump's recent interest in rescheduling marijuana from Schedule I to Schedule III opens the door to broader access in the country.
Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors
In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $1.03, denoting a -12.71% move from the preceding trading day.
Zacks·21d ago
Tilray Requests Extension To Regain Compliance With Nasdaq, Retail Investors Call It A ‘Smart Move
Tilray said it was evaluating several options, including, but not limited to, a stockholder-approved reverse stock split to address capital structure and maintain adherence to Nasdaq’s continued listing requirements.
This Cannabis Stock Popped 26% Today After Announcing Partnership With An Italian Company – Do You Own It?
Italian firm Molteni will collaborate with Tilray Medical’s subsidiary by providing targeted education on medical cannabis therapies through Molteni’s comprehensive network of pharmaceutical, scientific, and medical professionals throughout Italy.
Cannabis ETFs Soar as Trump Mulls Over Marijuana Reclassification
Cannabis ETFs like WEED, CNBS and MJ surge after Trump confirmed that his administration is weighing marijuana's move from Schedule I to Schedule III.
Zacks·24d ago